Literature DB >> 18656519

Successful treatment with Yi-Gan San for rapid eye movement sleep behavior disorder.

Hideto Shinno, Masahito Kamei, Yu Nakamura, Yasushi Inami, Jun Horiguchi.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18656519     DOI: 10.1016/j.pnpbp.2008.06.015

Source DB:  PubMed          Journal:  Prog Neuropsychopharmacol Biol Psychiatry        ISSN: 0278-5846            Impact factor:   5.067


× No keyword cloud information.
  13 in total

1.  Best practice guide for the treatment of REM sleep behavior disorder (RBD).

Authors:  R Nisha Aurora; Rochelle S Zak; Rama K Maganti; Sanford H Auerbach; Kenneth R Casey; Susmita Chowdhuri; Anoop Karippot; Kannan Ramar; David A Kristo; Timothy I Morgenthaler
Journal:  J Clin Sleep Med       Date:  2010-02-15       Impact factor: 4.062

2.  Effect of Yokukansan for the Treatment of Idiopathic Rapid Eye Movement Sleep Behavior Disorder: A Retrospective Analysis of Consecutive Patients.

Authors:  Kentaro Matsui; Taeko Sasai-Sakuma; Jun Ishigooka; Katsuji Nishimura; Yuichi Inoue
Journal:  J Clin Sleep Med       Date:  2019-08-15       Impact factor: 4.062

3.  REM sleep behavior disorder and REM sleep without atonia as an early manifestation of degenerative neurological disease.

Authors:  Stuart J McCarter; Erik K St Louis; Bradley F Boeve
Journal:  Curr Neurol Neurosci Rep       Date:  2012-04       Impact factor: 5.081

Review 4.  Treatment of REM Sleep Behavior Disorder.

Authors:  Youngsin Jung; Erik K St Louis
Journal:  Curr Treat Options Neurol       Date:  2016-11       Impact factor: 3.598

5.  Effects of geissoschizine methyl ether, an indole alkaloid in Uncaria hook, a constituent of yokukansan, on human recombinant serotonin 7 receptor.

Authors:  Toshiyuki Ueki; Akinori Nishi; Sachiko Imamura; Hitomi Kanno; Kazushige Mizoguchi; Kyoji Sekiguchi; Yasushi Ikarashi; Yoshio Kase
Journal:  Cell Mol Neurobiol       Date:  2012-09-12       Impact factor: 5.046

Review 6.  Current Concepts and Controversies in the Management of REM Sleep Behavior Disorder.

Authors:  E Matar; S J McCarter; E K St Louis; S J G Lewis
Journal:  Neurotherapeutics       Date:  2021-01-06       Impact factor: 7.620

7.  Yokukansan inhibits neuronal death during ER stress by regulating the unfolded protein response.

Authors:  Toru Hiratsuka; Shinsuke Matsuzaki; Shingo Miyata; Mitsuhiro Kinoshita; Kazuaki Kakehi; Shinji Nishida; Taiichi Katayama; Masaya Tohyama
Journal:  PLoS One       Date:  2010-10-12       Impact factor: 3.240

8.  Sleep disturbances associated with Parkinson's disease.

Authors:  Keisuke Suzuki; Masayuki Miyamoto; Tomoyuki Miyamoto; Masaoki Iwanami; Koichi Hirata
Journal:  Parkinsons Dis       Date:  2011-08-17

Review 9.  Serotonin Receptor Binding Characteristics of Geissoschizine Methyl Ether, an Indole Alkaloid in Uncaria Hook.

Authors:  Yasushi Ikarashi; Kyoji Sekiguchi; Kazushige Mizoguchi
Journal:  Curr Med Chem       Date:  2018       Impact factor: 4.530

Review 10.  Yokukan-san: a review of the evidence for use of this Kampo herbal formula in dementia and psychiatric conditions.

Authors:  Hideki Okamoto; Masaomi Iyo; Keigo Ueda; Cheolsun Han; Yoshiro Hirasaki; Takao Namiki
Journal:  Neuropsychiatr Dis Treat       Date:  2014-09-12       Impact factor: 2.570

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.